drugset / Trial / NCT03745664

Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)

NCT03745664 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Community-acquired pneumonia (CAP) is often complicated by elevation of cardiac troponin, a marker of myocardial injury, that can be isolated or associated to myocardial infarction (MI). A retrospective study showed that corticosteroid treatment lowers incidence of MI during the hospital-stay. The aim of this clinical trial is to examine whether in-hospital treatment with iv methylprednisolone (20 mg b.i.d) may reduce myocardial injury, as assessed by serum high-sensitivity cardiac T Troponin) and eventually cardiovascular events during a short- and long-term follow-up in patients hospitalized CAP.

Timeline

Start
2021-01-10
Primary completion
2023-05-16
Completion
2024-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 20 mg Intravenous

Indications